Outcome predictors in cocaine dependence treatment trials
- PMID: 17182445
- DOI: 10.1080/10550490600998476
Outcome predictors in cocaine dependence treatment trials
Abstract
Finding the predictors of outcome in outpatient cocaine dependence treatment trials may be useful for the development of both psychosocial as well as pharmacological treatments for cocaine dependence. Among the most powerful predictors of response to psychosocial treatment are cocaine withdrawal symptom severity and the results of a urine drug screen (UDS) collected at study entry. The present trial seeks to extend these findings by examining outcome predictors in a large number of subjects participating in a series of outpatient cocaine pharmacotherapy trials while selecting three separate criteria to define successful outcome. The ability of several baseline variables were tested to predict treatment outcome in a series of cocaine medication trials that included 402 cocaine-dependent subjects. Predictor variables included results from the baseline Addiction Severity Index (ASI), initial UDS results, and cocaine withdrawal symptom severity at treatment entry, as measured by scores on the Cocaine Selective Severity Assessment (CSSA). Outcome measures included UDS results obtained during the trials and results from the ASI gathered at the end of the trials. Baseline variables that most consistently predicted treatment outcome were the initial UDS results and initial CSSA scores. These findings indicate that baseline UDS results and CSSA scores are powerful predictors of outcome and should be used as stratifying variables in outpatient cocaine medication trials.
Similar articles
-
Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.Am J Addict. 2009 Jan-Feb;18(1):81-6. doi: 10.1080/10550490802545174. Am J Addict. 2009. PMID: 19219669 Free PMC article. Clinical Trial.
-
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.Drug Alcohol Depend. 2006 Nov 8;85(2):129-37. doi: 10.1016/j.drugalcdep.2006.04.002. Epub 2006 May 11. Drug Alcohol Depend. 2006. PMID: 16697124 Clinical Trial.
-
Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients.Am J Addict. 2008 Jan-Feb;17(1):60-4. doi: 10.1080/10550490701755999. Am J Addict. 2008. PMID: 18214724 Clinical Trial.
-
Treatment outcome predictors for cocaine dependence.Am J Drug Alcohol Abuse. 2007;33(2):191-206. doi: 10.1080/00952990701199416. Am J Drug Alcohol Abuse. 2007. PMID: 17497542 Review.
-
New developments in the pharmacotherapy of cocaine abuse.Addict Biol. 2007 Jun;12(2):133-51. doi: 10.1111/j.1369-1600.2007.00061.x. Addict Biol. 2007. PMID: 17508985 Review.
Cited by
-
Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.Psychopharmacology (Berl). 2012 Sep;223(2):179-90. doi: 10.1007/s00213-012-2705-1. Epub 2012 Apr 18. Psychopharmacology (Berl). 2012. PMID: 22526535
-
Footshock stress potentiates cue-induced cocaine-seeking in an animal model of relapse.Physiol Behav. 2009 Dec 7;98(5):614-7. doi: 10.1016/j.physbeh.2009.09.013. Epub 2009 Sep 30. Physiol Behav. 2009. PMID: 19800355 Free PMC article.
-
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.Drug Alcohol Depend. 2016 Jan 1;158:1-7. doi: 10.1016/j.drugalcdep.2015.11.004. Epub 2015 Nov 21. Drug Alcohol Depend. 2016. PMID: 26652899 Free PMC article. Review.
-
Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use.Psychopharmacology (Berl). 2021 Jun;238(6):1513-1529. doi: 10.1007/s00213-021-05782-2. Epub 2021 Feb 8. Psychopharmacology (Berl). 2021. PMID: 33558983 Free PMC article.
-
Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals.J Psychopharmacol. 2015 Mar;29(3):312-23. doi: 10.1177/0269881114562464. Epub 2015 Jan 7. J Psychopharmacol. 2015. PMID: 25567555 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical